ACADIA Pharmaceuticals Statistics
Total Valuation
ACAD has a market cap or net worth of $2.47 billion. The enterprise value is $1.77 billion.
| Market Cap | 2.47B |
| Enterprise Value | 1.77B |
Important Dates
The next estimated earnings date is Wednesday, May 7, 2025, after market close.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ACAD has 166.79 million shares outstanding. The number of shares has increased by 1.55% in one year.
| Current Share Class | 166.79M |
| Shares Outstanding | 166.79M |
| Shares Change (YoY) | +1.55% |
| Shares Change (QoQ) | +0.31% |
| Owned by Insiders (%) | 0.49% |
| Owned by Institutions (%) | 72.79% |
| Float | 114.38M |
Valuation Ratios
The trailing PE ratio is 10.90 and the forward PE ratio is 25.05. ACAD's PEG ratio is 2.39.
| PE Ratio | 10.90 |
| Forward PE | 25.05 |
| PS Ratio | 2.57 |
| Forward PS | 2.31 |
| PB Ratio | 3.37 |
| P/TBV Ratio | 4.03 |
| P/FCF Ratio | 15.73 |
| P/OCF Ratio | 15.68 |
| PEG Ratio | 2.39 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.67, with an EV/FCF ratio of 11.26.
| EV / Earnings | 7.81 |
| EV / Sales | 1.85 |
| EV / EBITDA | 17.67 |
| EV / EBIT | 21.00 |
| EV / FCF | 11.26 |
Financial Position
The company has a current ratio of 2.38, with a Debt / Equity ratio of 0.07.
| Current Ratio | 2.38 |
| Quick Ratio | 2.18 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 0.47 |
| Debt / FCF | 0.33 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 38.89% and return on invested capital (ROIC) is 8.27%.
| Return on Equity (ROE) | 38.89% |
| Return on Assets (ROA) | 5.44% |
| Return on Invested Capital (ROIC) | 8.27% |
| Return on Capital Employed (ROCE) | 10.63% |
| Revenue Per Employee | $1.46M |
| Profits Per Employee | $346,255 |
| Employee Count | 654 |
| Asset Turnover | 0.99 |
| Inventory Turnover | 13.33 |
Taxes
In the past 12 months, ACAD has paid $31.62 million in taxes.
| Income Tax | 31.62M |
| Effective Tax Rate | 12.25% |
Stock Price Statistics
The stock price has decreased by -11.41% in the last 52 weeks. The beta is 0.54, so ACAD's price volatility has been lower than the market average.
| Beta (5Y) | 0.54 |
| 52-Week Price Change | -11.41% |
| 50-Day Moving Average | 17.04 |
| 200-Day Moving Average | 16.82 |
| Relative Strength Index (RSI) | 41.57 |
| Average Volume (20 Days) | 1,723,193 |
Short Selling Information
The latest short interest is 15.62 million, so 9.36% of the outstanding shares have been sold short.
| Short Interest | 15.62M |
| Short Previous Month | 14.43M |
| Short % of Shares Out | 9.36% |
| Short % of Float | 13.65% |
| Short Ratio (days to cover) | 9.88 |
Income Statement
In the last 12 months, ACAD had revenue of $957.80 million and earned $226.45 million in profits. Earnings per share was $1.36.
| Revenue | 957.80M |
| Gross Profit | 572.71M |
| Operating Income | 84.28M |
| Pretax Income | 45.74M |
| Net Income | 226.45M |
| EBITDA | 100.16M |
| EBIT | 84.28M |
| Earnings Per Share (EPS) | $1.36 |
Balance Sheet
The company has $755.99 million in cash and $52.00 million in debt, giving a net cash position of $704.00 million or $4.22 per share.
| Cash & Cash Equivalents | 755.99M |
| Total Debt | 52.00M |
| Net Cash | 704.00M |
| Net Cash Per Share | $4.22 |
| Equity (Book Value) | 732.79M |
| Book Value Per Share | 4.40 |
| Working Capital | 543.45M |
Cash Flow
In the last 12 months, operating cash flow was $157.72 million and capital expenditures -$523,000, giving a free cash flow of $157.20 million.
| Operating Cash Flow | 157.72M |
| Capital Expenditures | -523,000 |
| Free Cash Flow | 157.20M |
| FCF Per Share | $0.94 |
Margins
Gross margin is 59.79%, with operating and profit margins of 8.80% and 23.64%.
| Gross Margin | 59.79% |
| Operating Margin | 8.80% |
| Pretax Margin | 26.94% |
| Profit Margin | 23.64% |
| EBITDA Margin | 10.46% |
| EBIT Margin | 8.80% |
| FCF Margin | 16.41% |
Dividends & Yields
ACAD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.55% |
| Shareholder Yield | -1.55% |
| Earnings Yield | 9.16% |
| FCF Yield | 6.36% |
Analyst Forecast
The average price target for ACAD is $23.93, which is 61.36% higher than the current price. The consensus rating is "Buy".
| Price Target | $23.93 |
| Price Target Difference | 61.36% |
| Analyst Consensus | Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (5Y) | 10.93% |
| EPS Growth Forecast (5Y) | 15.70% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ACAD has an Altman Z-Score of 2.99 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.99 |
| Piotroski F-Score | 4 |